Clinical Trials Logo

Clinical Trial Summary

This is a prospective, randomized, blinded study with a parallel design and an allocation ratio of 1:1 for the treatment groups. The investigators seek to determine if femoral nerve block (FNB) improves the quality of recovery and improve postoperative analgesia compared with adductor canal block (ACBs) for patients undergoing revision total knee arthroplasty.


Clinical Trial Description

This is a prospective, randomized, blinded study with a parallel design and an allocation ratio of 1:1 for the treatment groups. A prospective study design will allow both FNBs and ACBs to be accurately assessed in an effective manner without introducing unnecessary confounding factors. Furthermore, randomization and a parallel design with equal allocation ratio will ensure timely enrollment of patients while also minimizing temporal confounders that may occur with institutional changes to clinical care protocols. Patients, nurses on the floor and physical therapists will be blinded to the nature of the patient assignment (FNB or ACB) ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03697538
Study type Interventional
Source University of Pennsylvania
Contact
Status Terminated
Phase N/A
Start date October 10, 2018
Completion date June 27, 2022

See also
  Status Clinical Trial Phase
Withdrawn NCT05253976 - PMCF Study on the Safety, Performance and Clinical Benefits Data of the NexGen TM Augmentation Patella
Active, not recruiting NCT03153475 - ATTUNE Revision System in the Revision Total Knee Arthroplasty Population N/A
Recruiting NCT05314491 - Multigen Plus CCK and AMF TT Cones Follow Up Study
Completed NCT03274466 - Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty N/A
Completed NCT02877381 - Tranexamic Acid in Revision Total Joint Arthroplasty Phase 4
Not yet recruiting NCT01482533 - Tissue Culture Versus Swab Culture in Prosthetic Joint Infections N/A